Prolynx names CFO and CSO to advance obesity drug portfolio
Go back to Prolynx names CFO and CSO to advance obesity drug portfolio| (NASDAQ: CLLS) | Delayed: 3.12 +0.08 (2.63%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.04 | 52 Week High | $37.55 | |||
| Open | $3.12 | 52 Week Low | $16.35 | |||
| Day High | $3.12 | P/E | N/A | |||
| Day Low | $3.12 | EPS | $0.00 | |||
| Volume | 199 | |||||
| Ram Gold & Exploration, Inc. (NASDAQ: MGX) | Delayed: 1.21 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.21 | 52 Week High | $0.65 | |||
| Open | $1.21 | 52 Week Low | $0.65 | |||
| Day High | $1.21 | P/E | N/A | |||
| Day Low | $1.21 | EPS | $0.00 | |||
| Volume | 9,560 | |||||
